Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma

NCT00477412 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Methotrexate
BIOLOGICAL: Rituximab
DRUG: Vincristine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]